The relative contribution of antibody production and CD8+ T cell function to immune control of Trypanosoma cruzi

Parasite Immunology

Volumn 20, Issue 5, 1998, Pages 207-216

  Kumar, Sudesh ^a   Tarleton, Rick L ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Chagas' disease; CTL; Cytotoxic T lymphocytes; Granzyme B; Immunoglobulins; Perforin; Trypanosoma cruzi; Vaccine

Indexed keywords

CD8 ANTIGEN; IMMUNOGLOBULIN; PERFORIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; B LYMPHOCYTE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HOST PARASITE INTERACTION; HOST RESISTANCE; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

ANIMALIA; MAMMALIA; PROTOZOA; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0031859154     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3024.1998.00154.x     Document Type: Conference Paper

References (69)

1. Abrahamsohn I.A. & Coffman R.L. (1996) Trypanosoma cruzi: IL-10 TNF IFN-gamma and IL-12 regulate innate and acquired immunity to infection. Experimented Parasitology 84, 231-244
2. Almeida I.C., Milani S.R., Gorin P.A. & Travassos L.R. (1991) Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-alpha-galactosyl antibodies. Journal of Immunology 146, 2394-2400
3. Ando K, Hiroishi K., Kaneko T. et al. (1997) Perforin Fas/Fas ligand and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. Journal of Immunology 158, 5283-5291
4. Araujo F. (1989) Development of resistance to Trypanosoma cruzi in mice depends on a viable population of L3T4+ (CD4+) T lymphocytes. Infection & Immunity 57, 2246-2248
5. Atkinson E.A. & Bleackley R.C. (1995) Mechanisms of lysis by cytotoxic T cells. Critical Reviews in Immunology 15, 359-384
6. Berke G. (1995) The CTL's kiss of death. Cell 81, 9-12
7. Brener Z. (1986) Why vaccines do not work in Chagas' disease. Parasitology Today 2, 196-197
8. Brodskyn C.I., Silva A.M.M., Takehara H.A. & Mota I. (1989) IgG subclasses responsible for immune clearance in mice infected with Trypanosoma cruzi. Immunology Cell. Biology 67, 343-348
9. Clark W.R., Walsh C.M., Glass A.A., Huang M.T., Ahmed R. & Matloubian M. (1995) Cell-mediated cytotoxicity in perforin-less mice. International Kinetics in Immunology 13, 1-14
10. De Miranda-Santos I.K., & Compos-Neto A. (1981) Receptor for immunoglobulin Fc on pathogenic but not on nonpathogenic protozoa of the Trypanosomatidae. Journal of Experimental Medicine 154, 1732-1742
11. Denkers E.Y., Yap G., Scharton-Kersten T. et al. (1997) Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii. Journal of Immunology 159, 1903-1908
12. Elkon K.B., Liu C.C., Gall J.G. et al. (1997) Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors. Proceedings of the National Academy of Sciences USA 94, 9814-9819
13. Frost P., Ng C.P., Belldegrun A. & Bonavida B. (1997) Immunosensitization of prostate carcinoma cell lines for lymphocytes (CTL TIL LAK)-mediated apoptosis via the Fas-Fas-ligand pathway of cytotoxicity. Cell Immunology 180, 70-83
14. Garcia I.E., Lima M.R., Marinho C.R. et al. (1997a) Role of membrane-bound IgM in Trypanosoma cruzi evasion from immune clearance. Jounal of Parasitology 83, 230-233
15. Garcia S., Fevrier M., Dadaglio G., Lecoeur H., Riviere Y. & Gougeon M.L. (1997b) Potential deleterious effect of anti-viral cytotoxic lymphocyte through the CD95 (FAS/APO-1)-mediated pathway during chronic HIV infection. Immunological Letters 57, 53-58
16. Gazzinelli R.T., Oswald I.P., Hieny S., James S.L. & Sher A. (1992) The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. European Journal of Immunology 22, 2501-2506
17. Griffith T.S., Brunner T., Fletcher S.M., Green D.R. & Ferguson T.A. (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270, 1189-1192
18. Guidotti L.G. & Chisari F.V. (1996) To kill or to cure: options in host defense against viral infection. Current Opinion in Immunology 8, 478-483
19. Hall B.F. & Joiner K.A. (1993) Developmentally-regulated virulence factors of Trypanosoma cruzi and their relationship to evasion of host defences. J Eukaryot Microbiol 40, 207-213
20. Harth G., Mills A.A., Lin T. & Araujo F.G. (1994) Trypanosoma cruzi glycoprotein of M(r) 56000 characterization and assessment of its potential to protect against fatal parasite infections. Molecular Microbiology 11, 261-271
21. Heusel J.W., Wesselschmidt R.L., Shresta S., Russell J.H. & Ley T.J. (1994) Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76, 977-987
22. Hunter C.A., Ellis-Neyes L.A., Slifer T. et al. (1997) IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. Journal of Immunology 158, 3311-3316
23. Joiner K.A., daSilva W.D., Rimoldi M.T., Hammer C.H., Sher A. & Kipnis T.L. (1988) Biochemical characterization of a factor produced by trypomastigotes of Trypanosoma cruzi that accelerates the decay of complement C3 convertases. Journal of Biological Chemistry 263, 11327-11335
24. Kagi D. & Hensgartner H. (1996a) Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses. Current Opinion in Immunology 8, 472-477
25. Kagi D., Ledermann B., Buerki K., Hengartner H. & Zinkernagel R.M. (1994a) CD8+ T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity. European Journal of Immunology 24, 3068-3072
26. Kagi D., Ledermann B., Burki K., Zinkernagel R.M. & Hengartner H. (1996b) Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annual Reviews in Immunology 14, 207-232
27. Kagi D., Vignaux F., Ledermann B. et al. (1994b) Fas and perforin pathways as major mechanisms of T-cell mediated cytotoxicity. Science 265, 528-530
28. Kitamura D., Roes J., Kuhn R. & Rajewsky K. (1991) A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350, 423-426
29. Koller B.H., Marrack P., Kappler J.W. & Smithies O. (1990) Normal development of mice deficient in beta-2-microglobulin MHC class I proteins and CD8+ T cells. Science 248, 1227-1230
30. Krettli A.U. & Brener Z. (1982) Resistance against Trypanosoma cruzi associated to anti-living trypomastigote antibodies. Journal of Immunology 128, 2009-2012
31. Lages-Silva E., Ramirez L.E., Krettli A.U. & Brener Z. (1987) Effect of protective and non-protective antibodies in the phagocytosis rate of Trypanosoma cruzi blood forms by mouse peritoneal macrophages. Parasite Immunology 9, 21-30
32. Laochumroonvorapong P., Wang J., Liu C.C. et al., (1997) Perforin a cytotoxic molecule which mediates cell necrosis is not required for the early control of mycobacterial infection in mice. Infection and Immunology 65, 127-132
33. Lima-Martins M.V.C., Sanchez G.A., Krettli A.U. & Brener Z. (1985) Antibody-dependent cell cytotoxicity against Trypanosoma cruzi is only mediated by protective antibodies. Parasite Immunology 7, 367-376
34. Low H.P., Santos M.A.M., Wizel B. & Tarleton R.L. (1997) Amastigote surface proteins of Trypanosoma cruzi are targets for CD8+ cytotoxic T lymphocytes. Journal of Immunology (in press)
35. Lowin B., Hahne M., Mattmann C. & Tschopp J. (1994) Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370, 650-652
36. Metz G., Carlier Y. & Vray B. (1993) Trypanosoma cruzi upregulates nitric oxide release by IFN-gamma-preactivated macrophages limiting cell infection independently of the respiratory burst. Parasite Immunology 15, 693-699
37. Mota I. & Umekita L.F. (1989) The effect of C3 depletion on the clearance of Trypanosoma cruzi induced by IgG antibodies. Immunology Letters 21, 223-226
38. Munoz-Fernandez M.A., Fernandez M.A. & Fresno M. (1992) Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. European Journal of Immunology 22, 301-307
39. Murfin D.J. & Kuhn R.E. (1989) Relative resistance of Brazil strain trypomastigote forms of Trypanosoma cruzi to in vitro antibody-dependent complement-mediated lysis. Journal of Parasitology 74, 1046-1050
40. Nakamoto Y., Guidotti L.G., Pasquetto V., Schreiber R.D. & Chisari F.V. (1997) Differential target cell sensitivity to CTL-activated death pathways in hepatitis B virus transgenic mice. Journal of Immunology 158, 5692-5697
41. Nickell S.P., Stryker G.A. & Arevalo C. (1993) Isolation from Trypanosoma cruzi-infected mice of CD8+ MHC-restricted cytotoxic T cells that lyse parasite-infected target cells. Journal of Immunology 150, 1446-1457
42. Norris K., Harth G. & So M. (1989) Purification of a Trypanosoma cruzi membrane glycoprotein which elicits lytic antibodies. Infection and Immunity 57, 2372-2379
43. Renggli J., Hahne M., Matile H., Betschart B., Tschopp J. & Corradin G. (1997) Elimination of P. berghei liver stages is independent of Fas (CD95/Apo-I) or perforin-mediated cytotoxicity. Parasite Immunology 19, 145-148
44. Rimoldi M.T., Tartanian A. & Joiner K.A. (1989) Lytic rabbit IgG for tissue culture trypomastigotes of Trypanosoma cruzi alters the extent and form of complement deposition. Experimental Parasitology 68, 160-167
45. Rodriguez A.M., Santoro F., Afchain D., Bazin H. & Capron H. (1981) Trypanosoma cruzi infection in B-cell deficient rats. Parasite Immunology 31, 524-529
46. Rottenberg M.E., Bakhiet M., Olsson T., Kristensson K., Mak T., Wigzell H. & Orn A. (1993) Differential susceptibilities of mice genomically deleted of CD4 and CD8 to infections with Trypanosoma cruzi or Trypanosoma brucei. Infection and Immunity 61, 5129-5133
47. Rottenberg M.E., Cardoni R.L., Titto E.H., Moreno M. & Segura E.L. (1988) Trypanosoma cruzi: Immune response in mice immunized with parasite antigens. Experimental Parasitology 65, 101-108
48. Rottenberg M.E., Riarte A., Sporrong L. et al. (1995a) Outcome of infection with different strains of Trypanosoma cruzi in mice lacking CD4 and/or CD8. Immunology Letters 45, 53-60
49. Rottenberg M.E., Sporrong L., Persson I., Wigzell H. & Orn A. (1995b) Cytokine gene expression during infection of mice lacking CD4 and/ or CD8 with Trypanosoma cruzi. Scandinavian Journal of Immunology 41, 164-170
50. Rotzschke O., Falk K., Stevanovic S., Jung G., Walden P. & Rammensee H.G. (1991) Exact prediction of a natural T cell epitope. European Journal of Immunology 21, 2891-2894
51. Ruiz A.M., Esteva M., Riarte A., Subias E. & Segura E.L. (1986) Immunoprotection of mice against Trypanosoma cruzi with a lyophilized flagellar fraction of the parasite plus adjuvant. Immunology Letters 12, 1-4
52. Santos Lima E.C. & Minoprio P. (1996) Chagas' disease is attenuated in mice lacking gamma delta T cells. Infection and Immunology 64, 215-221
53. Schenkman S., Guther M.L. & Yoshida N. (1986) Mechanism of resistance to lysis by the alternative complement pathway in Trypanosoma cruzi trypomastigotes: effect of specific monoclonal antibody. Journal of Immunology 137, 1623-1628
54. Scott M.T. & Moyes L. (1982) 75Se-methionine labelled Trypanosoma cruzi blood trypomastigotes: opsonization by chronic infection serum facilitates killing in spleen and liver. Clinical and Experimental Immunology 48, 754-757
55. Sher A., Hieny S. & Joiner K. (1986) Evasion of the alternative complement pathway by metacyclic trypomastigotes of Trypanosoma cruzi: dependence on the developmentally regulated synthesis of surface protein and N-linked carbohydrate. Journal of Immunology 137, 2961-2967
56. Spinella S., Liegeard P. & Hontebeyrie J.M. (1992) Trypanosoma cruzi: predominance of IgG2a in nonspecific humoral response during experimental Chagas' disease. Experimental Parasitology 74, 46-56
57. Stenger S., Mazzaccaro R.J., Uyemura K, et al. (1997) Differential effects of cytolytic T cell subsets on intracellular infection. Science 276, 1684-1687
58. Sutton V.R., Vaux D.L. & Trapani J.A. (1997) Bcl-2 prevents apoptosis induced by perforin and granzyme B but not that mediated by whole cytotoxic lymphocytes. Journal of Immunology 158, 5783-5790
59. Tang Y., Hugin A.W., Giese N.A. et al. (1997) Control of immunodeficiency and lymphoproliferation in mouse AIDS: studies of mice deficient in CD8+ T cells or perforin. Journal of Virology 71, 1808-1813
60. Tarleton R.L. (1990) Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi. Journal of Immunology 144, 717-724
61. Tarleton R.L. (1997) Immunity to Trypanosoma cruzi. In Host Response to Intracellular Pathogens S.H.E. Kaufmann ed. R.G. Landes Company, Austin, TX, pp. 227-247
62. Tarleton R.L., Grusby M.J., Postan M. & Glimcher L.H. (1996) Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I-and class II-restricted T cells in immune resistance and disease. International Immunology 8, 13-22
63. Tarleton R.L., Koller B.H., Latour A. & Postan M. (1992) Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 356, 338-340
64. Tomlinson S., Pontes de Carvalho L.C., Vandekerckhove F. & Nussenzweig V. (1994) Role of sialic acid in the resistance of Trypanosoma cruzi trypomastigotes to complement. Journal of Immunology 153, 3141-3147
65. Trischmann T.M. (1983) Non-antibody mediated control of parasitemia in acute experimental Chagas' disease. Journal of Immunology 130, 1953-1957
66. Trischmann T.M. (1984) Role of cellular immunity in protection against Trypanosoma cruzi in mice. Parasite Immunology 6, 561-570
67. Van Kaer L., Ashton-Rickardt P.G., Ploegh H.L. & Tonegawa S. (1992) TAP1 mutant mice are deficient in antigen presentation surface class I molecules and CD4-8+ T cells. Cell 71, 1205-1214
68. Vespa G.N., Cunha F.Q. & Silva J.S. (1994) Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infection and Immunity 62, 5177-5182
69. Wizel B., Nunes M. & Tarleton R.L. (1997) Identification of a Trypanosoma cruzi trans-sialidase family member as a target of protective CD8+ Tcl responses. Journal of Immunology 159, 6120-6130